8 Jul | Malnutrition costs businesses US$850bn – Weight management shifts away from "just" weight loss – Fermented collagen touts “unmatched” bioavailability – Effervescent C BD-alternative with Gencor's PEA

Chronic underinvestment in fighting malnutrition and obesity in the workforce costs businesses in low- and middle-income countries up to US$850 billion per year in productivity losses. This is the main finding of a new report entitled The Business Case for Investment in Nutrition, published by Chatham House and Vivid Economics. It highlights that it is in the interest of businesses to improve nutritional outcomes among their workers as an “investment in tomorrow’s workforce” – whether signs of malnutrition are visible throughout the workforce or not.

Evolva’s health ingredients segment has seen a considerable increase in growth and demand for its resveratrol products. With over 13,000 published studies examining its effects, resveratrol is known as a powerful antioxidant and anti-inflammatory agent. Clare Panchoo, Global Vice President, Health Ingredients, elaborates on resveratrol’s immunity-boosting properties, the company’s new resveratrol product launch and in which regional markets functional beverages are surging. She also shares how a new financial investment is set to strengthen Evolva’s position in the health ingredients sector.